Preliminary BB2 Trial Results Presented at the 9th South African TB Conference

Prof. Jason E. Farley was invited as a plenary speaker at the 9th SA TB Conference in Johannesburg, South Africa to present on the interim preliminary blinded outcomes of the Bring BPaL2Me (BB2) Clinical Trial. Both arms of the trial have 90%+ success rates of the 50% of enrollees thus far.